Key facts
- Notable investors include Wuxi Capital, SDIC Juli Investment.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Zhongke Kangyuan Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongke Kangyuan Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongke Kangyuan Biotechnology
Manufacturer of biological conversion technologies intended for agricultural and environmental applications. The company offers microbial fermentation, enzyme engineering, biomass pretreatment, and nutrient optimization processes, enabling the agriculture and animal husbandry market to improve feed efficiency, reduce dependence on conventional grain resources, enhance sustainability through waste utilization, lower production costs, support healthier livestock growth, and achieve scalable ecological benefits while maintaining consistent performance across diverse production environments.
- Sector
- Healthcare
- HQ
- Tangshan, China
- Founded
- 2018
- Employees
- 58
- Ownership
- Privately Held (backing)
Zhongke Kangyuan Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongke Kangyuan Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongke Kangyuan Biotechnology in its N-PORT filings yet. We sweep new filings monthly.